NCT02880319View on ClinicalTrials.gov

Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone

PHASE2Active, not recruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

November 29, 2016

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2027

Conditions

Bone Cancer

Interventions

DRUG

Stereotactic Body Radiation Therapy (SBRT)

DEVICE

Stereotactic Linear Accelerator

Trial Locations (1)

02115

Dana Farber Cancer Institute, Boston

All Listed Sponsors

lead

Dana-Farber Cancer Institute

OTHER